ZENTALIS PHARMACEUTICALS INC
ZNTLNASDAQ🏆 #3249 by market capEarnings Nov 9US Equity
$2.72▲ $0.12 (+4.42%)
🌙 After hours$2.72▲ 0.18%Regular close · extended-hours price shownTrack ZNTL
Get earnings, price moves & breaking news on Telegram
24h▲ 4.4%
7d▼ 5.1%
14d▼ 12.3%
30d▼ 27.8%
ytd▲ 101.9%
1y▲ 78.6%
🏦Market Cap
$193M
Small Cap
📈Revenue Growth (YoY)
—
📊Gross Margin
—
💵FCF Margin
—
⚖️P/S Ratio
—
Otter Score
68
Fair
ZENTALIS PHARMACEUTICALS INC
ZNTLAnalyst Ratings
Price
$2.72
Total
12
Raised
0
Lowered
0
Avg PT
$8.33
H / L
$10 / $5
| Institution | Action | Rating | Date | Upside | |
|---|---|---|---|---|---|
Guggenheim | Reiterated | Buy | 2026-04-10 | $10.00 | +268.30% |
Morgan Stanley | Reiterated | Equal Weight | 2025-11-12 | $5.00 | +84.20% |
Wells Fargo | Reiterated | Equal Weight | 2025-08-07 | — | — |
Wedbush | Reiterated | Neutral | 2025-05-15 | $4.00 | +47.30% |
HC Wainwright & Co. | Reiterated | Buy | 2025-05-15 | — | — |
UBS | Reiterated | Neutral | 2025-01-28 | — | — |
Oppenheimer | Reiterated | Outperform | 2024-09-16 | — | — |
Stifel | Reiterated | Buy | 2024-06-18 | — | — |
Jefferies | Reiterated | Buy | 2023-05-19 | $6.00 | +121.00% |
SVB Leerink | Reiterated | Outperform | 2022-11-10 | — | — |
Cowen & Co. | Reiterated | Outperform | 2022-07-12 | — | — |
Cantor Fitzgerald | Reiterated | Overweight | 2020-09-29 | — | — |
Institution
Guggenheim
Reiterated · Buy · 2026-04-10
$10.00
+268.30%
Morgan Stanley
Reiterated · Equal Weight · 2025-11-12
$5.00
+84.20%
Wells Fargo
Reiterated · Equal Weight · 2025-08-07
—
—
Wedbush
Reiterated · Neutral · 2025-05-15
$4.00
+47.30%
HC Wainwright & Co.
Reiterated · Buy · 2025-05-15
—
—
UBS
Reiterated · Neutral · 2025-01-28
—
—
Oppenheimer
Reiterated · Outperform · 2024-09-16
—
—
Stifel
Reiterated · Buy · 2024-06-18
—
—
Jefferies
Reiterated · Buy · 2023-05-19
$6.00
+121.00%
SVB Leerink
Reiterated · Outperform · 2022-11-10
—
—
Cowen & Co.
Reiterated · Outperform · 2022-07-12
—
—
Cantor Fitzgerald
Reiterated · Overweight · 2020-09-29
—
—
One row per institution · price target from the firm's latest published target
StockOtter · stockotter.space